The role of presensitizing murine recipients with donor spleen matched at multiple minor histocompatibility loci. These cells prior to T cell-depleted or -repleted H-2 compatible allodonor-host combinations differ with respect to the Gpi-1 geneic bone marrow transplantation (BMT) was investigated at phenotype which allows determination of the level of donor two different doses of total body irradiation (TBI). Recipients blood chimerism as described previously.
ments, a transplanted bone marrow cell dose of 10 7 nucleated marrow transplantation; total body irradiation cells was used. Spleen cells were collected from the donors and enriched for T cells by passing the cells over a nylonwool column according to a method described by Julius et al. 8 T Graft-versus-host disease (GVHD) still remains a major comcell-enriched spleen cell suspensions were added to the bone plication after allogeneic bone marrow transplantation marrow so that each mouse received 2 × 10 6 T cells (20% (BMT).
1 Methods of depleting T lymphocytes from the donor of the total marrow dose) or none at all. The different cell bone marrow graft have successfully decreased the incidence suspensions were injected intravenously at 4-6 h after the end of GVHD but these are associated with an increasing number of irradiation. of engraftment failures as well as leukemic relapses.
1,2 These In mixed lymphocyte cultures (MLC), normal B6 spleen problems have prompted a number of investigators to study responder cells were not reactive against H-2 compatible the role of donor T lymphocytes on murine bone marrow BALB.B cells. However, B6 spleen cells that were presensitengraftment. 3, 4 The most important factors for engraftment ized in vivo against BALB.B cells demonstrated a significant appear to be the number of donor cells in the graft, the extent immune response (data not shown). The frequency of proliferof host preparation and the degree of genetic difference ating T lymphocytes (pPTL) in B6 spleen cells reactive against between donor and recipient. In addition, BMT patients often H-2 compatible BALB.B cells was determined in a 7-day limitreceive blood transfusions prior to transplantation which may ing dilution culture of B6 responder cells in the presence of immunize the patient against allogeneic cells. This preirradiated (20 Gy) donor (BALB.B) stimulator cells as immunization induced a high incidence of bone marrow graft described. 9 This frequency was increased by about 100-fold rejection, especially in aplastic anemia patients who are preat 1 week after presensitization with BALB.B cells when compared with less intense conditioning regimens. 5 The relative pared with unsensitized animals ( Figure 1 ). Total body role of pre-immunization in T cell-depleted BMT is not irradiation with 6 or 9.5 Gy reduced the numbers of pPTL per known.
spleen but the residual number of lymphocyte precursors in We have investigated the roles of donor T lymphocytes and presensitized animals was significantly higher than in unsensihost presensitization in an H-2-matched murine BMT model tized mice. at two different doses of total body irradiation (TBI). These
Transplantation of H-2-matched BM into B6 mice that were variables were compared in one experimental system where conditioned with a sublethal dose of 6 Gy did not reach a survival as well as donor chimerism were principle endpoints. between T cell-depleted and -repleted BMT (data not shown).
Figure 1
Immune reactivity in B6 mice as measured by pPTL frequencies in response to H-2 compatible (BALB.B) cells. Host and donor spleen cells were cultured as responders and irradiated stimulator cells respectively and 3 H-Tdr uptake was determined after 7 days. Spleen cells were collected from irradiated hosts at 24 h after TBI (without a BMT). Frequencies with 95% confidence intervals were calculated and are shown as error bars. Presensitized mice were injected with 2 × 10 7 irradiated donor cells on day −7.
A TBI dose of 9.5 Gy is potentially lethal and requires at least transient engraftment of transplanted bone marrow to survive the acute effects of radiation. Unsensitized recipients prepared with 9.5 Gy TBI demonstrated good survival and achieved full donor engraftment as early as 8 weeks post-BMT, whereas presensitized recipients all died early from acute marrow failure with no evidence of donor type chimerism (Figure 2b ). The recovery of peripheral leukocyte and erythrocyte counts after 6 Gy TBI and BMT was delayed in presensitized recipients while this was not altered by T cell repletion (data not shown). Comparison between erythroid engraftment and engraftment among the lymphohemopoietic tissues on termination of the experiment at 20 weeks post-BMT showed that only in spleen and thymus were higher engraftment levels found in unsensitized mice (6 Gy TBI) that inoculum. 10 In that model, BMT led to GVHD when low doses of T cells were added back to T-depleted marrow 4,10 whereas in the current study a relatively high number of T cells neither
The results presented in this paper show that an enhanced alloreactivity following recipient presensitization leads to a improved engraftment nor significantly led to GVHD severe enough to induce lethality.
very marked rejection of allogeneic marrow. This was predicted from measurements obtained from the MLC and pPTL In contrast to the lack of a T cell effect on engraftment in the two BMT models mentioned above, it was recently shown assays. The results also suggest that radiation dose is critical for allogeneic engraftment and survival in presensitized anithat CD8-positive lymphocytes were able to facilitate engraftment of class II MHC-disparate marrow and of marrow mals. TBI doses of 6 Gy and above were enough to induce donor chimerism in unsensitized recipients of H-2 matched heterozygous for class I and II MHC.
11 It is therefore likely that the actual type of genetic disparity between donor and BMT. 4, 7, 9, 12 In presensitized animals bone marrow was promptly rejected but the low TBI dose allowed survival host mice as well as the number of T cells transplanted determines whether or not donor T cells can have a positive effect through recovery of host hemopoiesis. Raising the TBI dose to 9.5 Gy did not appear to be adequate enough to prevent rejecon engraftment. A similar phenomenon may exist among BMT patients were there is an association between graft failure and tion of allogeneic bone marrow in presensitized mice. This led to death from acute bone marrow aplasia. Under conditions of T cell depletion of the graft.
